Skip to main navigation
Skip to content
Corcept Corcept
Main Menu
  • Contact Us
  • About
    • About Corcept
    • Board of Directors
    • Executive Team
    • Educational Grants
    • Contact Us
  • Product
    • Korlym® for Cushing's Syndrome
    • Medical Information Request
  • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigator-Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Working at Corcept
    • Benefits
    • Testimonials
    • Current Opportunities

SEC Filing Details

Home - Investor Relations - SEC Filings - 4

SEC Filing Details

Document Details

Form
4
Filing Date
Sep 15, 2021
Document Date
Sep 13, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Corcept
Issuer
CORCEPT THERAPEUTICS INC
Filer
Robb Gary Charles

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

Shareholder Tools

Email Alerts
Print Page
RSS Feeds

Footer Menu

  • About
    • Executive Team
    • Board of Directors
    • Educational Grants
    • Contact Us
  • Product
    • Korlym for Cushing's Syndrome
    • Medical Information Request
    • Patients
  • Research & Pipeline
    • Cortisol Modulation
    • Cortisol Modulation Therapeutic Platform
    • Pipeline and Clinical Trials
    • Publications
    • Investigators Initiated Studies
    • Compassionate Use
  • Investors
    • Investors Overview
    • Press Releases
    • Events
    • Corporate Governance
    • Analyst Coverage
    • Stock Information
    • SEC Filings
  • Careers
    • Benefits
    • Testimonials
    • Current Opportunities
©  2023 Corcept
  • Privacy Policy
  • Terms of Use
  • Site Map